PISCATAWAY, N.J. – Camber Pharmaceuticals recently announced the addition of naproxen oral suspension to its current portfolio.

Naproxen oral suspension is indicated for the relief of the signs and symptoms of:

• rheumatoid arthritis
• osteoarthritis
• ankylosing spondylitis
• polyarticular juvenile idiopathic arthritis
• tendonitis
• bursitis
• acute gout

The management of:

• pain
• primary dysmenorrhea

Naproxen oral suspension from Camber is available in 125 mg/5 mL strength in 500 mL bottles.